Zimbabwe has turned down a substantial US health deal worth 367 million US dollars (272 million pounds) spanning five years because of the United States' insistence on confidential information.
This move came to light following a official document dated December was leaked, which showed President Emmerson Mnangagwa felt the deal was "lopsided".
An official spokesperson has since stated that the United States was seeking genetic material for research and commercial purposes while was unwilling to guarantee the benefits from any future vaccines.
"We will now turn to the challenging and unfortunate process of ending our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy said the United States had furnished over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has appealed for more talks to find a deal agreeable to both sides so the nation's vital HIV programme can be sustained.
Wider Context
This development comes after a similar case in neighbouring Kenya, where a court halted a similar health funding agreement after legal challenges were filed about the safety of citizens' health data.
After returning to the presidency recently, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
USAID had managed assistance for the American government, but Trump claimed its expenditure was "wasteful" and his government was seeking government-to-government agreements to boost transparency and accountability.
According to statements, Sixteen African countries have to date signed similar health pacts, representing more than $18.3bn in committed funds.
Details of the Rejected Agreement
The money for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this cooperation might have yielded extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million presently on HIV treatment through American-funded programmes," Tremont commented.
However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".
"The proposal required Zimbabwe to provide its genetic material and health information for a long time, without any corresponding guarantee of access to any medical innovations – like new medicines or tests – that might result from that provided information," his statement read.
"Put simply, our country would supply the basic resources for medical research with no assurance that the final treatments would be available to our citizens should a future pandemic emerge."
National Interest and Global Health
He also said that the American exit from the global health body and its pursuit of one-on-one health agreements were disrupting systems previously established through the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing scheme created to deal with future pandemics.
"This mechanism is designed to guarantee that when a nation provides its information, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the resources to create them."
The government's concerns regarding the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We encourage ongoing discussions with our US partners on how future collaboration might be structured in a manner that honours the independence and interests of each country."
Health Experts Reaction
A leading public health body expressed it understood the official position, but urged that negotiations must proceed given that a large portion of the nation's Aids initiatives depended on foreign aid.
"If specific concerns arise, including those involving information security or agreement terms, these can frequently be resolved through detailed discussion and mutually agreed protections," the group added.
The situation underscores the continuing tensions between accepting crucial foreign assistance and safeguarding national sovereignty in an ever more interconnected world.